Risk factors for chronic rejection in pediatric renal allograft recipients. 1996

C Guyot, and J M Nguyen, and P Cochat, and M Foulard, and F Bouissou, and R Van Damme-Lombaerts, and C Loirat, and F Janssen, and A Bensman, and H Nivet, and M Fischbach, and J P Guignard, and J L André
Centre Hôspitalier Régional, Nantes, France.

To determine the risk factors predictive of graft loss from chronic rejection in pediatric renal allograft recipients, we reviewed the collaborative study database of the Société de Néphrologie Pédiatrique which registered 314 grafts from January 1987 to December 1991. Of the 289 grafts analyzed, 71 failed during follow-up, chronic rejection being the most common cause of graft loss (35%). The clinical features of the chronic rejection group (n = 25) were compared with those of the group without failure (n = 218). The variables tested by monovariate analysis were cyclosporine dose at 1 year, donor type, donor and recipient age, and acute rejection episodes. The incidence of graft loss due to chronic rejection was 4% (4/109) in patients who had no acute rejection and 16% (21/134) in those with at least one acute rejection episode (P = 0.002). Donor age (< or = 5 years) was a risk factor for chronic rejection (P = 0.024). Recipient age and donor type were not significantly different between the chronic rejection group and the control group. Using time-dependent covariates, the risk factors were an acute rejection episode (P = 0.003) and low cyclosporine doses at 1 year (P = 0.02). We conclude that acute rejection and low cyclosporine doses in these pediatric patients were risk factors for graft loss due to chronic rejection.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003195 Computer Communication Networks A system containing any combination of computers, computer terminals, printers, audio or visual display devices, or telephones interconnected by telecommunications equipment or cables: used to transmit or receive information. (Random House Unabridged Dictionary, 2d ed) Cognitive Radio,Computer Network Management,Databases, Distributed,Distributed Systems,Extranets,Intranets,Network Communication Protocols,Telecommunication Networks,Cognitive Radios,Communication Network, Computer,Communication Networks, Computer,Communication Protocol, Network,Communication Protocols, Network,Computer Communication Network,Database, Distributed,Distributed Database,Distributed Databases,Distributed System,Extranet,Intranet,Management, Computer Network,Network Communication Protocol,Network Management, Computer,Network, Computer Communication,Network, Telecommunication,Protocol, Network Communication,Radio, Cognitive,System, Distributed,Telecommunication Network
D005260 Female Females
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

C Guyot, and J M Nguyen, and P Cochat, and M Foulard, and F Bouissou, and R Van Damme-Lombaerts, and C Loirat, and F Janssen, and A Bensman, and H Nivet, and M Fischbach, and J P Guignard, and J L André
April 1993, Transplantation,
C Guyot, and J M Nguyen, and P Cochat, and M Foulard, and F Bouissou, and R Van Damme-Lombaerts, and C Loirat, and F Janssen, and A Bensman, and H Nivet, and M Fischbach, and J P Guignard, and J L André
June 1996, Transplantation proceedings,
C Guyot, and J M Nguyen, and P Cochat, and M Foulard, and F Bouissou, and R Van Damme-Lombaerts, and C Loirat, and F Janssen, and A Bensman, and H Nivet, and M Fischbach, and J P Guignard, and J L André
August 1997, Pediatric nephrology (Berlin, Germany),
C Guyot, and J M Nguyen, and P Cochat, and M Foulard, and F Bouissou, and R Van Damme-Lombaerts, and C Loirat, and F Janssen, and A Bensman, and H Nivet, and M Fischbach, and J P Guignard, and J L André
January 2000, Nephron,
C Guyot, and J M Nguyen, and P Cochat, and M Foulard, and F Bouissou, and R Van Damme-Lombaerts, and C Loirat, and F Janssen, and A Bensman, and H Nivet, and M Fischbach, and J P Guignard, and J L André
July 2014, Zhonghua yi xue za zhi,
C Guyot, and J M Nguyen, and P Cochat, and M Foulard, and F Bouissou, and R Van Damme-Lombaerts, and C Loirat, and F Janssen, and A Bensman, and H Nivet, and M Fischbach, and J P Guignard, and J L André
July 1977, Annals of surgery,
C Guyot, and J M Nguyen, and P Cochat, and M Foulard, and F Bouissou, and R Van Damme-Lombaerts, and C Loirat, and F Janssen, and A Bensman, and H Nivet, and M Fischbach, and J P Guignard, and J L André
February 1996, Kidney international,
C Guyot, and J M Nguyen, and P Cochat, and M Foulard, and F Bouissou, and R Van Damme-Lombaerts, and C Loirat, and F Janssen, and A Bensman, and H Nivet, and M Fischbach, and J P Guignard, and J L André
January 2018, International journal of organ transplantation medicine,
C Guyot, and J M Nguyen, and P Cochat, and M Foulard, and F Bouissou, and R Van Damme-Lombaerts, and C Loirat, and F Janssen, and A Bensman, and H Nivet, and M Fischbach, and J P Guignard, and J L André
January 2017, International journal of organ transplantation medicine,
C Guyot, and J M Nguyen, and P Cochat, and M Foulard, and F Bouissou, and R Van Damme-Lombaerts, and C Loirat, and F Janssen, and A Bensman, and H Nivet, and M Fischbach, and J P Guignard, and J L André
June 1994, Clinical transplantation,
Copied contents to your clipboard!